Supply Chain | December 23, 2023
UPM Biomedicals enters into distribution agreement with Brinter for GrowInk bioinks
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
Development services for gene and cell therapies is planned to begin first in 2025
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
Five batches across four programs of Biocon Academy participated in the graduation ceremony
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US
The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market
Evinova will operate as a separate health-tech business within AstraZeneca
XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer
Subscribe To Our Newsletter & Stay Updated
